Article Information
History
- May 23, 2024.
Article Versions
- Version 1 (May 20, 2024 - 13:49).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Nasim Zakibakhsh1,
- Sajjad Basharpoor1,*,
- Hamidreza Ghalyanchi Langroodi2,
- Mohammad Narimani1,
- Michael A Nitsche3,4,5 and
- Mohammad Ali Salehinejad3,6,*
- 1Department of Psychology, Faculty of Educational Sciences and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran
- 2Clinical Development and Research Unit, Ghaem Hospital, Guilan University of Medical Sciences, Rasht, Iran
- 3Department of Psychology and Neurosciences, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
- 4Bielefeld University, University Hospital OWL, Protestant Hospital of Bethel Foundation, University Clinic of Psychiatry and Psychotherapy, Bielefeld, Germany
- 5German Center for Mental Health (DZPG), Bochum, Germany
- 6School of Cognitive Sciences, Institute for Research in Fundamental Sciences, Tehran, Iran
- ↵*Correspondence: Mohammad Ali Salehinejad & Sajjad Basharpoor salehinejadmohammadali{at}gmail.com basharpoor_sajjad{at}uma.ac.ir
Posted May 23, 2024.
Prefrontal tDCS for improving mental health and cognitive deficits in patients with Multiple Sclerosis: a randomized, double-blind, parallel-group study
